ES2143990T3 - Utilizacion de factores de crecimiento de hepatocitos para la fabricacion de un multiplicador de celulas cepa hematopoyeticas. - Google Patents
Utilizacion de factores de crecimiento de hepatocitos para la fabricacion de un multiplicador de celulas cepa hematopoyeticas.Info
- Publication number
- ES2143990T3 ES2143990T3 ES92916220T ES92916220T ES2143990T3 ES 2143990 T3 ES2143990 T3 ES 2143990T3 ES 92916220 T ES92916220 T ES 92916220T ES 92916220 T ES92916220 T ES 92916220T ES 2143990 T3 ES2143990 T3 ES 2143990T3
- Authority
- ES
- Spain
- Prior art keywords
- proliferating
- cell multiplier
- hematopoietic stem
- hepatocyte
- hepatocitos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE PRESENTA UN MULTIPLICADOR DE CELULAS MADRE HEMATOPOIETICOS QUE COMPRENDE AL MENOS UN FACTOR PROLIFERATIVO DE HEPATOCITOS COMO INGREDIENTE ACTIVO. A CAUSA DE QUE LOS FACTORES PROLIFERATIVOS DE HEPATOCITOS TIENEN UNA ACTIVIDAD PROLIFERATIVA DE CELULAS MADRE, INDEFERENCIADAS PLURIPOTENCIALES, HEMATOPOIETICOS SON UTILES COMO MULTIPLICADORES DE CELULAS DE TRONCO HEMATOPOIETICO NO SOLAMENTE EN EL TRATAMIENTO DE LA INHIBICION E INSUFICIENCIA DE LA MEDULA OSEA SINO QUE TAMBIEN SON UTILES PARA EFECTUAR EL CRECIMIENTO IN VITRO DE CELULAS MADRE DE SANGRE PERIFERICA Y CELULAS MADRE DE MEDULA OSEA. ADEMAS ES POSIBLE OBTENER POR DERIVACION UN FACTOR PROLIFERATIVO DE HEPATOCITOS A PARTIR DE FIBROBLASTOS HUMANOS NORMALES, ENTRE OTROS FACTORES PROLIFERATIVOS DE HEPATOCITOS, MEDIANTE TECNICAS DE RECOMBINACION DE GENES, Y EL FACTOR PROLIFERATIVO OBTENIDO ES TAMBIEN UTIL COMO MULTIPLICADOR DE CELULAS MADRE HEMATOPOIETICOS.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18748191 | 1991-07-26 | ||
| JP18747091 | 1991-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2143990T3 true ES2143990T3 (es) | 2000-06-01 |
Family
ID=26504364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92916220T Expired - Lifetime ES2143990T3 (es) | 1991-07-26 | 1992-07-24 | Utilizacion de factores de crecimiento de hepatocitos para la fabricacion de un multiplicador de celulas cepa hematopoyeticas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6221359B1 (es) |
| EP (1) | EP0550769B1 (es) |
| JP (1) | JP3395181B2 (es) |
| AT (1) | ATE191501T1 (es) |
| CA (1) | CA2092542A1 (es) |
| DE (1) | DE69230879T2 (es) |
| ES (1) | ES2143990T3 (es) |
| WO (1) | WO1993003061A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1271088B (it) * | 1994-11-24 | 1997-05-26 | Dompe Spa | Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche |
| US5824789A (en) * | 1995-06-07 | 1998-10-20 | Systemix, Inc. | Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof |
| US5728581A (en) * | 1995-06-07 | 1998-03-17 | Systemix, Inc. | Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
| CN1222310C (zh) * | 1998-08-05 | 2005-10-12 | 住友制药株式会社 | 肝实质细胞增殖因子药用制剂 |
| WO2004085616A2 (en) * | 2003-03-24 | 2004-10-07 | The Uab Research Foundation | Regulation of self-renewal in stem cells |
| EP1613742A2 (en) * | 2003-04-08 | 2006-01-11 | YEDA RESEARCH AND DEVELOPMENT Co. LTD. | Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| FR2853551B1 (fr) | 2003-04-09 | 2006-08-04 | Lab Francais Du Fractionnement | Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee |
| CA2537246A1 (en) * | 2003-09-03 | 2005-03-17 | Kringle Pharma Inc. | Skin ulcer preventive or curative agent containing human recombinant hgf |
| JP4716875B2 (ja) | 2003-12-16 | 2011-07-06 | 敏一 中村 | 糖鎖欠損型肝細胞増殖因子 |
| JP5093783B2 (ja) | 2006-04-20 | 2012-12-12 | クリングルファーマ株式会社 | Hgf前駆体蛋白質改変体及びその活性型蛋白質 |
| CN103743906B (zh) * | 2013-07-24 | 2015-05-20 | 北京大学人民医院 | 用于测定造血干细胞移植后患者骨髓微环境的试剂盒、系统及方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2564486B2 (ja) * | 1986-07-14 | 1996-12-18 | 修治 橋本 | 肝細胞増殖因子 |
| US5362716A (en) * | 1989-12-27 | 1994-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
| DE69131069T2 (de) * | 1990-07-13 | 1999-07-15 | Snow Brand Milk Products Co., Ltd., Sapporo, Hokkaido | Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung |
-
1992
- 1992-07-24 JP JP50346393A patent/JP3395181B2/ja not_active Expired - Fee Related
- 1992-07-24 ES ES92916220T patent/ES2143990T3/es not_active Expired - Lifetime
- 1992-07-24 EP EP92916220A patent/EP0550769B1/en not_active Expired - Lifetime
- 1992-07-24 DE DE69230879T patent/DE69230879T2/de not_active Expired - Fee Related
- 1992-07-24 AT AT92916220T patent/ATE191501T1/de not_active IP Right Cessation
- 1992-07-24 WO PCT/JP1992/000949 patent/WO1993003061A1/ja not_active Ceased
- 1992-07-24 CA CA002092542A patent/CA2092542A1/en not_active Abandoned
- 1992-07-24 US US08/030,410 patent/US6221359B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69230879D1 (de) | 2000-05-11 |
| EP0550769A4 (es) | 1994-04-27 |
| JP3395181B2 (ja) | 2003-04-07 |
| CA2092542A1 (en) | 1993-01-27 |
| ATE191501T1 (de) | 2000-04-15 |
| WO1993003061A1 (fr) | 1993-02-18 |
| EP0550769B1 (en) | 2000-04-05 |
| DE69230879T2 (de) | 2000-08-03 |
| US6221359B1 (en) | 2001-04-24 |
| EP0550769A1 (en) | 1993-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nakahara et al. | Culture‐expanded human periosteal‐derived cells exhibit osteochondral potential in vivo | |
| Piche et al. | Initial characterization of cells derived from human periodontia | |
| Olsson et al. | Repigmentation of vitiligo by transplantation of cultured autologous melanocytes. | |
| ES2143990T3 (es) | Utilizacion de factores de crecimiento de hepatocitos para la fabricacion de un multiplicador de celulas cepa hematopoyeticas. | |
| AU8476698A (en) | Human mesenchymal stem cells from peripheral blood | |
| CA2339182A1 (en) | Improvement of cardiac function by mesenchymal stem cell transplantation | |
| DE3590594T1 (es) | ||
| EP0590156A4 (en) | Novel, physiologically active protein and hemopoietic stem cell growth promoter | |
| ES2147720T3 (es) | Factor de celulas madre. | |
| DE502004011252D1 (de) | Verwendung des erythropoietins zur regeneration von lebergewebe | |
| CA2131385A1 (en) | Methods, compositions and devices for maintaining and growing human stem or hematopoietic cells | |
| CO5580844A2 (es) | Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas | |
| GR3034195T3 (en) | New cultures of keratinocytes, process for their preparation and their use as wound healing substances. | |
| DE69332350D1 (de) | Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen | |
| Errick et al. | Growth and differentiation in cultured human thyroid cells: effects of epidermal growth factor and thyrotropin | |
| DK0549774T3 (da) | Anvendelse af porøst calciumcarbonat som bærermateriale for in vitro cellekulturer | |
| ATE444078T1 (de) | Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen | |
| YU217890A (sh) | Postupak za dobijanje genetskih konstrukcija za ekspresiju nervnog faktora rasta u eukariotskim ćelijama | |
| CN113151165B (zh) | 一种人脐带间充质干细胞扩增用培养基及培养方法 | |
| NZ506510A (en) | A permanent skin replacement comprising allogenic epithelial cells cultured in vitro and autologous epithelial cells | |
| CA2227241A1 (en) | Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment | |
| Smets | Agglutination with Con A dependent on cell cycle | |
| EP0163543A3 (en) | Marrow cell stimulator | |
| ATE225183T1 (de) | Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen | |
| Benayahu et al. | Bone formation by marrow osteogenic cells (MBA‐15) is not accompanied by osteoclastogenesis and generation of hematopoietic supportive microenvironment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 550769 Country of ref document: ES |